Abstract

Objective: Newer magnetic resonance imaging (MRI) techniques have shown promise in capturing early Parkinson disease (PD)-related changes in the substantia nigra pars compacta (SNc), the key pathological loci. Their translational value, however, is hindered by technical complexity and inconsistent results. Methods: A novel yet simple MRI contrast, the T1w/T2w ratio, was used to study 76 PD patients and 70 controls. The T1w/T2w ratio maps were analyzed using both voxel-based and region-of-interest approaches in normalized space. The sensitivity and specificity of the SNc T1w/T2w ratio in discriminating between PD and controls also were assessed. In addition, its diagnostic performance was tested in a subgroup of PD patients with disease duration ≤2 years (PDE). A second independent cohort of 73 PD patients and 49 controls was used for validation. Results: Compared to controls, PD patients showed a higher T1w/T2w ratio in both the right (cluster size = 164mm 3 , p < 0.0001) and left (cluster size = 213mm 3 , p < 0.0001) midbrain that was located ventrolateral to the red nucleus and corresponded to the SNc. The region-of-interest approach confirmed the group difference in the SNc T1w/T2w ratio between PD and controls (p < 0.0001). The SNc T1w/T2w ratio had high sensitivity (0.908) and specificity (0.80) to separate PD and controls (area under the curve [AUC] = 0.926), even for PDE patients (AUC = 0.901, sensitivity = 0.857, specificity = 0.857). These results were validated in the second cohort. Interpretation: The T1w/T2w ratio can detect PD-related changes in the SNc and may be used as a novel, parsimonious in vivo biomarker for the disease, particularly for early stage patients, with high translational value for clinical practice and research. ANN NEUROL 2019;85:96–104.

Original languageEnglish (US)
Pages (from-to)96-104
Number of pages9
JournalAnnals of Neurology
Volume85
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Parkinson Disease
Magnetic Resonance Spectroscopy
Sensitivity and Specificity
Area Under Curve
Magnetic Resonance Imaging
Red Nucleus
Mesencephalon
Pars Compacta
Biomarkers
Research

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

@article{645222a5418542c7a9439aec83d21b8f,
title = "Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease",
abstract = "Objective: Newer magnetic resonance imaging (MRI) techniques have shown promise in capturing early Parkinson disease (PD)-related changes in the substantia nigra pars compacta (SNc), the key pathological loci. Their translational value, however, is hindered by technical complexity and inconsistent results. Methods: A novel yet simple MRI contrast, the T1w/T2w ratio, was used to study 76 PD patients and 70 controls. The T1w/T2w ratio maps were analyzed using both voxel-based and region-of-interest approaches in normalized space. The sensitivity and specificity of the SNc T1w/T2w ratio in discriminating between PD and controls also were assessed. In addition, its diagnostic performance was tested in a subgroup of PD patients with disease duration ≤2 years (PDE). A second independent cohort of 73 PD patients and 49 controls was used for validation. Results: Compared to controls, PD patients showed a higher T1w/T2w ratio in both the right (cluster size = 164mm 3 , p < 0.0001) and left (cluster size = 213mm 3 , p < 0.0001) midbrain that was located ventrolateral to the red nucleus and corresponded to the SNc. The region-of-interest approach confirmed the group difference in the SNc T1w/T2w ratio between PD and controls (p < 0.0001). The SNc T1w/T2w ratio had high sensitivity (0.908) and specificity (0.80) to separate PD and controls (area under the curve [AUC] = 0.926), even for PDE patients (AUC = 0.901, sensitivity = 0.857, specificity = 0.857). These results were validated in the second cohort. Interpretation: The T1w/T2w ratio can detect PD-related changes in the SNc and may be used as a novel, parsimonious in vivo biomarker for the disease, particularly for early stage patients, with high translational value for clinical practice and research. ANN NEUROL 2019;85:96–104.",
author = "Guangwei Du and Mechelle Lewis and Christopher Sica and Lan Kong and Xuemei Huang",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/ana.25376",
language = "English (US)",
volume = "85",
pages = "96--104",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

Magnetic resonance T1w/T2w ratio : A parsimonious marker for Parkinson disease. / Du, Guangwei; Lewis, Mechelle; Sica, Christopher; Kong, Lan; Huang, Xuemei.

In: Annals of Neurology, Vol. 85, No. 1, 01.01.2019, p. 96-104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Magnetic resonance T1w/T2w ratio

T2 - A parsimonious marker for Parkinson disease

AU - Du, Guangwei

AU - Lewis, Mechelle

AU - Sica, Christopher

AU - Kong, Lan

AU - Huang, Xuemei

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Newer magnetic resonance imaging (MRI) techniques have shown promise in capturing early Parkinson disease (PD)-related changes in the substantia nigra pars compacta (SNc), the key pathological loci. Their translational value, however, is hindered by technical complexity and inconsistent results. Methods: A novel yet simple MRI contrast, the T1w/T2w ratio, was used to study 76 PD patients and 70 controls. The T1w/T2w ratio maps were analyzed using both voxel-based and region-of-interest approaches in normalized space. The sensitivity and specificity of the SNc T1w/T2w ratio in discriminating between PD and controls also were assessed. In addition, its diagnostic performance was tested in a subgroup of PD patients with disease duration ≤2 years (PDE). A second independent cohort of 73 PD patients and 49 controls was used for validation. Results: Compared to controls, PD patients showed a higher T1w/T2w ratio in both the right (cluster size = 164mm 3 , p < 0.0001) and left (cluster size = 213mm 3 , p < 0.0001) midbrain that was located ventrolateral to the red nucleus and corresponded to the SNc. The region-of-interest approach confirmed the group difference in the SNc T1w/T2w ratio between PD and controls (p < 0.0001). The SNc T1w/T2w ratio had high sensitivity (0.908) and specificity (0.80) to separate PD and controls (area under the curve [AUC] = 0.926), even for PDE patients (AUC = 0.901, sensitivity = 0.857, specificity = 0.857). These results were validated in the second cohort. Interpretation: The T1w/T2w ratio can detect PD-related changes in the SNc and may be used as a novel, parsimonious in vivo biomarker for the disease, particularly for early stage patients, with high translational value for clinical practice and research. ANN NEUROL 2019;85:96–104.

AB - Objective: Newer magnetic resonance imaging (MRI) techniques have shown promise in capturing early Parkinson disease (PD)-related changes in the substantia nigra pars compacta (SNc), the key pathological loci. Their translational value, however, is hindered by technical complexity and inconsistent results. Methods: A novel yet simple MRI contrast, the T1w/T2w ratio, was used to study 76 PD patients and 70 controls. The T1w/T2w ratio maps were analyzed using both voxel-based and region-of-interest approaches in normalized space. The sensitivity and specificity of the SNc T1w/T2w ratio in discriminating between PD and controls also were assessed. In addition, its diagnostic performance was tested in a subgroup of PD patients with disease duration ≤2 years (PDE). A second independent cohort of 73 PD patients and 49 controls was used for validation. Results: Compared to controls, PD patients showed a higher T1w/T2w ratio in both the right (cluster size = 164mm 3 , p < 0.0001) and left (cluster size = 213mm 3 , p < 0.0001) midbrain that was located ventrolateral to the red nucleus and corresponded to the SNc. The region-of-interest approach confirmed the group difference in the SNc T1w/T2w ratio between PD and controls (p < 0.0001). The SNc T1w/T2w ratio had high sensitivity (0.908) and specificity (0.80) to separate PD and controls (area under the curve [AUC] = 0.926), even for PDE patients (AUC = 0.901, sensitivity = 0.857, specificity = 0.857). These results were validated in the second cohort. Interpretation: The T1w/T2w ratio can detect PD-related changes in the SNc and may be used as a novel, parsimonious in vivo biomarker for the disease, particularly for early stage patients, with high translational value for clinical practice and research. ANN NEUROL 2019;85:96–104.

UR - http://www.scopus.com/inward/record.url?scp=85057115785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057115785&partnerID=8YFLogxK

U2 - 10.1002/ana.25376

DO - 10.1002/ana.25376

M3 - Article

C2 - 30408230

AN - SCOPUS:85057115785

VL - 85

SP - 96

EP - 104

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -